Liver surgery and risk of liver failure study
Part of Digestive system clinical trials.
This study looks at how the amount of healthy liver tissue removed during surgery affects the risk of liver failure after the operation. It is for people with common types of liver cancer (HCC or ICC) who are having a planned liver resection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned liver surgery (not an emergency).
- You have been diagnosed with either hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC).
- Your complete medical records are available for review.
- You have not had a special two-stage liver procedure called ALPPS or a procedure to block a liver blood vessel (portal vein embolization).
- Your tumor has not ruptured (burst open).
- The surgery is only on your liver—no other organs (like stomach, intestines, or spleen) are being removed at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that collects real-world information about people with liver failure or “pre-liver failure.” It aims to help doctors choose the best management approach for patients like you and improve care over time.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This study tests a procedure called portal vein embolization (PVE) to help grow the healthy part of the liver before surgery. It may be an option for people with certain liver cancers who need more healthy liver tissue before their operation.
This study looks at your liver health before and after surgery to predict the risk of “acute-on-chronic liver failure,” which means a sudden worsening of liver function on top of an existing liver condition. If you qualify, your doctors may use study data to better identify who needs closer monitoring after surgery.
This study tests whether removing part of the liver along with the spleen during laparoscopic (keyhole) surgery helps improve liver function and the immune system in people with liver cancer and cirrhosis. If you qualify, you may have better surgical outcomes and recovery.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.